ភាគហ៊ុនរបស់ AbbVie បំបែកដោយសង្ខេបលើកិច្ចព្រមព្រៀងមហារីកថ្មី 30 លានដុល្លារ

AbbVie (អេប៊ីប៊ីវី) stock briefly broke out Friday after the company signed a $30 million deal with small biotech Immunome (IMNM) in antibody development.




X



Immunome will use its platform to discover up to 10 new antibody pairs that could be used to treat cancer, the companies said in a news release. AbbVie will have the option to purchase worldwide rights for the antibodies arising from the deal.

“Immunome’s approach has the potential to unlock novel cancer biology and yield multiple therapeutic candidates,” AbbVie’s Steve Davidsen said in a written statement. Davidsen is the company’s vice president of oncology discovery research.

On ផ្សារហ៊ុនថ្ងៃនេះ, AbbVie stock climbed 1.9% to close at 166.55.

AbbVie Stock Briefly Tops Buy Point

Immunome has a platform based on human memory B cells. These cells are key players in the immune system.

The news sent AbbVie stock past a ចំណុចទិញ នៅ 167.85 ចេញពី a មូលដ្ឋានពែងជាមួយចំណុចទាញ, យោង​ទៅ​តាម MarketSmith.com. Shares later fell below their entry. Immunome stock initially surged more than 27%, but shares closed up just a fraction.

Under the terms of the deal, AbbVie will pay Immunome $30 million upfront. Immunome will also receive up to $70 million in payments based on AbbVie’s continued use of the Immunome platform and a max of $120 million in commercial milestones per target.

AbbVie stock has a high ការវាយតម្លៃសមាសធាតុ of 93 out of a total 99. This puts shares in the leading 7% of all stocks in terms of fundamental and technical measures, អេឌីឌីឌីជីថល shows. Immunome has a lower CR of 33.

តាម Allison Gatlin នៅលើ Twitter នៅ @IBD_AGatlin.

អ្នកអាចចូលចិត្តបានផងដែរ៖

Biogen Could Get A Second Alzheimer’s OK — But Will Wild Card Medicare Bite?

Genetics, Alzheimer’s And AI — Why 2023 Could Be The Year For Biotech Stocks

ជម្រើសជួញដូរ៖ វិធីចាប់ផ្តើមប្រើជម្រើសវិធីគ្រប់គ្រងហានិភ័យ

ការធ្វើពាណិជ្ជកម្មរយៈពេលខ្លីអាចបន្ថែមប្រាក់ចំណេញធំ។ SwingTrader របស់ក្រុមហ៊ុន IBD បង្ហាញអ្នកពីរបៀប

មើលយុទ្ធសាស្រ្តវិនិយោគរបស់អិល។ ឌី។ អេ។ បង្ហាញសម្រាប់ការយល់ដឹងអំពីទីផ្សារដែលអាចធ្វើសកម្មភាពបាន

Source: https://www.investors.com/news/technology/abbvie-stock-briefly-breaks-out-on-a-new-cancer-deal/?src=A00220&yptr=yahoo